학술논문
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
Document Type
Article
Author
Younes, Anas; Brody, Joshua; Carpio, Cecilia; Lopez-Guillermo, Armando; Ben-Yehuda, Dina; Ferhanoglu, Burhan; Nagler, Arnon; Ozcan, Muhit; Avivi, Irit; Bosch, Francesc; Caballero Barrigón, Maria Dolores; Hellmann, Andrzej; Kuss, Bryone; Ma, David D F; Demirkan, Fatih; Yağci, Münci; Horowitz, Netanel A; Marlton, Paula; Cordoba, Raul; Wrobel, Tomasz; Buglio, Daniela; Streit, Michael; Hodkinson, Brendan P; Schaffer, Michael; Alvarez, John; Ceulemans, Rob; Balasubramanian, Sriram; de Jong, Jan; Wang, Shean-Sheng; Fourneau, Nele; Jurczak, Wojciech
Source
In The Lancet Haematology February 2019 6(2):e67-e78
Subject
Language
ISSN
2352-3026